Synergy CHC Corp. (SNYRQ): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$8.33M

Year ended 2025-12-31

-$10.84M

Trailing 12 months to 2026-03-31

2015-12-31 EBITDA (USD) 2025-12-31

Period ended	EBITDA	Change YoY	Source filing
2025-12-31	-$8.33M	n/m	2026-04-01, From 2025-01-01
2024-12-31	$5.93M	-45.3%	2026-04-01, From 2024-01-01
2023-12-31	$10.84M	n/a	2025-03-31, From 2023-01-01
No annual figure between 2019-12-31 and 2023-12-31.
2019-12-31	-$6.74M	n/m	2020-04-29, From 2019-01-01
2018-12-31	-$3.10M	n/m	2020-04-29, From 2018-01-01
2017-12-31	$3.32M	-19.2%	2019-03-29, From 2017-01-01
2016-12-31	$4.10M	+275.2%	2018-04-02, From 2016-01-01
2015-12-31	$1.09M	n/a	2017-03-24, From 2015-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	EBITDA	Change YoY
Synergy CHC Corp. (SNYRQ)	2025-12-31	-$8.33M	n/m
C21 Investments Inc. (CWLXF)	2026-03-31	$4.06M	+35.8%
Leef Brands Inc. (LEEEF)	2025-12-31	-$6.33M	n/m
Cyanotech Corp (CYAN)	2025-03-31	-$1.03M	n/m
Charlie's Holdings, Inc. (CHUC)	2025-12-31	-$2.13M	n/m
Bon Natural Life Ltd (BON)	2025-09-30	-$535.6K	n/m
Fitlife Brands, Inc. (FTLF)	2025-12-31	$10.48M	-20.8%
Mannatech Inc (MTEX)	2025-12-31	$666.0K	-77.5%
Natural Alternatives International Inc (NAII)	2025-06-30	-$4.10M	n/m

Compare SNYRQ, CWLXF, LEEEF, CYAN side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗